Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher Disease

Author:

Blauwendraat Cornelis12ORCID,Tayebi Nahid3,Woo Elizabeth Geena3,Lopez Grisel3,Fierro Luca4,Toffoli Marco5,Limbachiya Naomi5,Hughes Derralynn6,Pitz Vanessa1ORCID,Patel Dhairya1,Vitale Dan27,Koretsky Mathew J.2,Hernandez Dena8,Real Raquel5,Alcalay Roy N.910ORCID,Nalls Mike A.278,Morris Huw R.5ORCID,Schapira Anthony H.V.5,Balwani Manisha4,Sidransky Ellen3

Affiliation:

1. Integrative Neurogenomics Unit, Laboratory of Neurogenetics, National Institute on Aging National Institutes of Health Bethesda Maryland USA

2. Center for Alzheimer's and Related Dementias, National Institute on Aging and National Institute of Neurological Disorders and Stroke National Institutes of Health Bethesda Maryland USA

3. Medical Genetics Branch, National Human Genome Research Institute National Institutes of Health Bethesda Maryland USA

4. Department of Genetics and Genomic Sciences Icahn School of Medicine at Mount Sinai New York New York USA

5. Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology University College London London United Kingdom

6. Lysosomal Storage Diseases Unit Royal Free London Hospital NHS Foundation Trust, and Department of Hematology, University College London London United Kingdom

7. Data Tecnica International Washington District of Columbia USA

8. Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging National Institutes of Health Bethesda Maryland USA

9. Department of Neurology Columbia University Irving Medical Center New York New York USA

10. Neurological Institute Tel Aviv Sourasky Medical Center Tel Aviv Israel

Abstract

AbstractBackgroundBiallelic pathogenic variants in GBA1 are the cause of Gaucher disease (GD) type 1 (GD1), a lysosomal storage disorder resulting from deficient glucocerebrosidase. Heterozygous GBA1 variants are also a common genetic risk factor for Parkinson's disease (PD). GD manifests with considerable clinical heterogeneity and is also associated with an increased risk for PD.ObjectiveThe objective of this study was to investigate the contribution of PD risk variants to risk for PD in patients with GD1.MethodsWe studied 225 patients with GD1, including 199 without PD and 26 with PD. All cases were genotyped, and the genetic data were imputed using common pipelines.ResultsOn average, patients with GD1 with PD have a significantly higher PD genetic risk score than those without PD (P = 0.021).ConclusionsOur results indicate that variants included in the PD genetic risk score were more frequent in patients with GD1 who developed PD, suggesting that common risk variants may affect underlying biological pathways. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.

Funder

Michael J. Fox Foundation

National Human Genome Research Institute

National Institute on Aging

National Institute of Neurological Disorders and Stroke

National Institutes of Health

Department of Health and Human Services

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3